Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.60 -5.24% 47.00 47.60 48.70 51.00 47.40 51.00 1,221,539 16:35:04
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -2.9 -1.0 - 121

Futura Medical Share Discussion Threads

Showing 16776 to 16799 of 21375 messages
Chat Pages: Latest  675  674  673  672  671  670  669  668  667  666  665  664  Older
DateSubjectAuthorDiscuss
09/5/2019
12:04
MikeIn what way is it risky, phase 2 tested 0.2mg dosage and it was successful, now they are testing the higher doses also. 0.2mg can go on market.Remember you can get med on prescription now but u have to request it.
neo26
09/5/2019
11:55
Yes of course you do
j777j
09/5/2019
11:49
I told you before why I am invested - because I believe in the product (CSD & MED) I told you before why I haven't bailed out - because I am hoping that I will one day get my money back - I don't actually need it but it is a matter of principle after all this time I am happy when the shares go up but want to inject a measure of caution when I see people like you encourage others (like me in the distant past) to invest in what still is, due incidentally entirely to the BoD, a risky share
mikethebike4
09/5/2019
10:37
So why are you invested ? Duh You clearly can't see the wood from the trees. You failed to capitalise on the placing. All you do is moan when the shares go up,so it it quite obvious which hymn sheet you are singing from. What a plonker
j777j
09/5/2019
09:35
J777J 8 May '19 - 15:38 - 5328 of 5331 0 3 0 These were trading at 90p a couple of years back on Med2002 prospects. Today they are a few months away from the most disruptive innovation in ED for two decades. EXACTLY the words used to describe CSD500 (the disruptive condom)2 or 3 years ago - only thing it disrupted was my wallet !
mikethebike4
09/5/2019
08:14
A few investors are waking up here, great stock could be one of the buys of 2019, along with ITX, TOOP, INFA, BOOM, SKIN etc
ny boy
09/5/2019
08:13
Went from 20p to 90p in a few days a couple of years back. I am not a seller as fully expect a similar pattern anytime.Only this time they are just months away from phase 3 trial results and the pain gel is also very close to the UK regulatory approval. You don't seem to understand the implications of having a blockbuster drug. Multibagger.com
j777j
09/5/2019
06:08
J777J, you missed out 'more than', as in 'they are more than a few months away...' Anyway, you've been quiet for a little while - busy cashing in a few chips I'd guess and I can't say I blame you after quite a successful pumping. Clearly you've no need of the product yourself!
glavey
08/5/2019
15:38
These were trading at 90p a couple of years back on Med2002 prospects.Today they are a few months away from the most disruptive innovation in ED for two decades.A global marketplace of around $6 billion and growing rapidly as global populations ages.
j777j
08/5/2019
14:46
Onwards to re test recent highs, before taking off
ny boy
08/5/2019
14:31
Added a few, lots to look forward to going forward, many of the small caps doing well lately, strong investor interest, ITX,TOOP,STX etc its all good in the hood Sir!
ny boy
08/5/2019
12:49
neo26 - I'm merely contextualising. I'm not stating one is imminent.
5oletrader
08/5/2019
12:03
pump and dump I fear.
freddievas
08/5/2019
11:16
5oleTraderYou on drugs. Fully funded for this year..
neo26
08/5/2019
11:10
Spot on, I struggled to get an order filled at 23.3
slong
08/5/2019
10:13
Can't you see this was a massive stop loss raid,in order that the MM's will get badly needed shares in order to satisfy the demand.
martinelwick
08/5/2019
09:55
Monthly Open + 4 trading days = 60%+ Rise / Divide by FOMO = Slap in the Face! “Calm Down Dear” Don't forget the recent dilution & placing at 7p. (300%+ Plus rise in 6 months) And still, No Monetisation. Timelines: Phase 3 data 'expected' END of 2019 (European only) 2nd Phase 3 study - data 'expected' END of 2020 (USA) EARLIEST Regulatory Submission in EU Q2 2020 - After Q4 2020 USA Extra Cash needed at some point. More Dilution at what price?!?
5oletrader
07/5/2019
16:23
If you are right remember who will be negotiating the price tho'
mikethebike4
07/5/2019
13:53
Some good posts by Ananda on LSE bulletin board.Worth reading, regarding read through valuation of Cialis.
wantage
07/5/2019
13:19
PAAAAANNNNIIIIICCC BUUUUYYYYIIINNNNGGGG!!! up 20% i think there is something very big on the way i think a MEGA Deal or even Buyout is on the way that could explaine the super rally here. If its a buyout then i hope it will be north of 1.50 GBP
ih_635590
07/5/2019
13:04
Oh look, someone from another planet.
glavey
07/5/2019
10:36
TUUUUUUUUUURRRRRRRRBBBBBOOOOOOOOO!!!!!! now at day high and market cap still at 60 million WHAT A LIFETIME OPPORTUNITY . With a US listing this stock would be close to a BILLION Dollar valuation or around £5 per share .so i hope FUM goes the same way like GW Pharma which exploding from $9 ipo to over $140 . THIS IS ONE OF THE BEST INVESTMENTS HERE!!!
ih_635590
07/5/2019
10:29
Market cap of 60 million (28p sp) ist still a PURE GIFT for this company Market cap 60 million /Cash 10.5 million / Potency Drug with 2 BILLION Market potential close to Phase 3 readout /CSD500 Condom approved in Europe and many Countries outside of Europa + more Approvals & Licensing deals coming / TPR100 (Topical Gel for Pain ) first approval expected next Quarter = POTENTIAL 10++ BAGGER GEM Futura Medical featured in Growth Company Investor recommendations 08 January 2019 CEO James Barder describes Futura as a medtech rather than biotech business. Its proprietary technology is DermaSys which delivers drugs rapidly through the skin and into the blood system. The lead product is MED2005 which is a topical gel for erectile dysfunction. The main advantage over Viagra is that it takes effect within five minutes, compared with over an hour for the famous blue pills. Which ensures key ingredients of spontaneity and mood can be retained while the treatment works. Research suggests a 20% market share could be possible, equating to sales of $560m in major western markets. In time an OTC version could more than double this.
ih_635590
06/5/2019
20:31
htTps://www.pharmaceutical-technology.com/features/new-treatments-erectile-dysfunction/ htTps://bigdeal.ft.com/videos/big-pharmas-billion-dollar-bets/ htTps://www.spiked-online.com/2019/02/14/three-cheers-for-new-viagra/ Fum is gettting attention, the gel works, advance stages in testing higher dosages, FUM state high chance of success. Sure a takeover targer. House Broker thinks they can take 20% market share in the ED market. One to watch for 2019.
neo26
Chat Pages: Latest  675  674  673  672  671  670  669  668  667  666  665  664  Older
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210506 22:16:43